Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Shanghai Junshi Biosciences (1877 HK)
Watchlist
212
Analysis
Health Care
•
China
Shanghai Junshi Biosciences Co., Ltd. operates as a biopharmaceutical company. The Company develops and sells small molecule drugs, antibody drug conjugates, and other products. Shanghai Junshi Biosciences markets its products worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Legend Biotech Corp
•
26 Jul 2022 11:44
Legend Biotech Follow-On - A Little Opportunistic. Last Deal Did Well, After a Large Correction
Legend Biotech Corp (LEGN US), a non-wholly owned subsidiary of Hong Kong-listed Genscript Biotech (1548 HK), is planning to raise up to US$250m in...
Sumeet Singh
Follow
305 Views
Share
bearish
•
Pharmaron Beijing
•
26 Jul 2022 09:04
Pharmaron Beijing Co Ltd (3759.HK/300759.CH) - The Story May Have Changed
Due to overcapacity/fierce competition,Pharmaron is hard to achieve V-shaped rebound by the strategy of "integration".We are conservative about its...
Xinyao (Criss) Wang
Follow
315 Views
Share
bearish
•
Thematic (Sector/Industry)
•
24 Jul 2022 09:11
China Healthcare Weekly (July22)-Jiangsu Province VBP, CStone's Potential Sale, Irrational Mr Market
Jiangsu Province released VBP results on medical consumables. CStone proposed a potential sale of the business.We analyzed the logic behind. Maybe...
Xinyao (Criss) Wang
Follow
364 Views
Share
bullish
•
Innovent Biologics Inc
•
21 Jul 2022 08:59
Innovent Biologics Inc (1801.HK) - Innovent Is Not Optional but Necessary in Portfolio
Innovent would transform from a biotech to biopharma. It is a better comprehensive choice of certainty, elasticity and safety than Hengrui. Its...
Xinyao (Criss) Wang
Follow
367 Views
Share
bearish
•
Thematic (Sector/Industry)
•
14 Jul 2022 09:24
Policy Interpretation of 2022 National Medical Insurance (NRDL) Negotiation
We analyzed the new policies, bidding rules, logic and impact on companies of 2022 NRDL adjustment,which will be very intense.The results will be...
Xinyao (Criss) Wang
Follow
218 Views
Share
First
Previous
14
15
16
17
18
19
20
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x